Javascript must be enabled to continue!
Construction of Recombinant Protein of Botulinum Neurotoxin Light Chain and Analysis of Cleavage Effect on VAMP1 Protein in Brown Rat
View through CrossRef
In order to explore the feasibility of the new rodenticide of type D Botulinum toxin to prevent and control the population density of pests in farmland from a molecular perspective. This study aimed to analyze the feasibility of D-type botulinum toxin for the control of urban rodents from a molecular perspective, and to detect the cleavage effect of D-type botulinum neurotoxin light chain recombinant protein on the synaptic vesicle membrane protein VAMP-1 of brown house mouse. The genomic DNA of Clostridium botulinum D 8901 strain was used as a template. Based on the botulinum toxin D gene sequence reported in GenBank, specific primers were designed. Plasmids were constructed by gene synthesis and subcloned into the pET28a expression vector. The recombinant plasmid was transformed into BL21 (DE3) Rosetta competent cells, and induced expression by IPTG. The expression products were purified by Ni-NTA affinity chromatography, identified by SDS-PAGE and Western blotting, and the recombinant proteins were analyzed by SDS-PAGE and Western blotting. The cleavage of VAMP1 protein in SD brown house mouse. The pET-28a- BDLc expression plasmid was successfully constructed and transformed into E. coli BL21 (DE3) Rosetta. Western blot confirmed that the recombinant protein pET-28a- BDLc (residues Met 1-Met 94) obtained soluble expression, and obtained 5 mg, Recombinant protein with purity > 90%. It has good biological activity as determined by animal method. The recombinant protein can decompose VAMP1 protein into two fragments. Type D botulinum toxin protein can specifically cleave synaptic vesicle membrane protein (VAMP1) of brown house mouse, and type D botulinum toxin is feasible for urban rodent control.
Science Publishing Group
Title: Construction of Recombinant Protein of Botulinum Neurotoxin Light Chain and Analysis of Cleavage Effect on VAMP1 Protein in Brown Rat
Description:
In order to explore the feasibility of the new rodenticide of type D Botulinum toxin to prevent and control the population density of pests in farmland from a molecular perspective.
This study aimed to analyze the feasibility of D-type botulinum toxin for the control of urban rodents from a molecular perspective, and to detect the cleavage effect of D-type botulinum neurotoxin light chain recombinant protein on the synaptic vesicle membrane protein VAMP-1 of brown house mouse.
The genomic DNA of Clostridium botulinum D 8901 strain was used as a template.
Based on the botulinum toxin D gene sequence reported in GenBank, specific primers were designed.
Plasmids were constructed by gene synthesis and subcloned into the pET28a expression vector.
The recombinant plasmid was transformed into BL21 (DE3) Rosetta competent cells, and induced expression by IPTG.
The expression products were purified by Ni-NTA affinity chromatography, identified by SDS-PAGE and Western blotting, and the recombinant proteins were analyzed by SDS-PAGE and Western blotting.
The cleavage of VAMP1 protein in SD brown house mouse.
The pET-28a- BDLc expression plasmid was successfully constructed and transformed into E.
coli BL21 (DE3) Rosetta.
Western blot confirmed that the recombinant protein pET-28a- BDLc (residues Met 1-Met 94) obtained soluble expression, and obtained 5 mg, Recombinant protein with purity > 90%.
It has good biological activity as determined by animal method.
The recombinant protein can decompose VAMP1 protein into two fragments.
Type D botulinum toxin protein can specifically cleave synaptic vesicle membrane protein (VAMP1) of brown house mouse, and type D botulinum toxin is feasible for urban rodent control.
Related Results
Botulinum Toxin Accessory Proteins: Are They Just an Accessory?
Botulinum Toxin Accessory Proteins: Are They Just an Accessory?
BACKGROUND
Botulinum neurotoxins produced by Clostridium botulinum consist of a complex of a core neurotoxin protein and one or more nontoxin accessory proteins. The ac...
Expression and characterization of rat kallikrein-binding protein in Escherichia coli
Expression and characterization of rat kallikrein-binding protein in Escherichia coli
Rat kallikrein-binding protein is a novel serine-proteinase inhibitor that forms a covalent complex with tissue kallikrein. We have purified rat kallikrein-binding protein and clon...
Runahead threads
Runahead threads
Los temas de investigación sobre multithreading han ganado mucho interés en la arquitectura de computadores con la aparición de procesadores multihilo y multinucleo. Los procesador...
VAMP1-Related Congenital Myasthenic Syndrome: A Case Report and Literature Review
VAMP1-Related Congenital Myasthenic Syndrome: A Case Report and Literature Review
Abstract
Congenital myasthenic syndrome-25 (CMS-25) is an autosomal recessive neuromuscular disorder caused by a homozygous mutation in VAMP1 gene. To date, only ...
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
The seventh in the series of ETP Symposia (see
Rapid Communications in Mass Spectrometry
2012,
26
, ...
Endothelial Protein C Receptor
Endothelial Protein C Receptor
IntroductionThe protein C anticoagulant pathway plays a critical role in the negative regulation of the blood clotting response. The pathway is triggered by thrombin, which allows ...
Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation
Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation
Endoproteolytic cleavage of the glycoprotein precursor to the mature SU and TM proteins is an essential step in the maturation of retroviral glycoproteins. Cleavage of the precurso...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
1.Effect of chronic haloperidol treatment on D‐2 receptors labelled by (3H)‐spiperone in homogenates of rat corpus striatum. A. L. Gundlach, D. J. de Vries and P. M. Beart2.The eff...

